ArticleSkin health and disease2026
Inequality and determinants of access to phototherapy among patients with psoriasis in Thailand.
Article in Skin health and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ultraviolet (UV) phototherapy is a cost-effective, guideline-recommended treatment for moderate-to-severe psoriasis, supported by extensive evidence demonstrating its long-term safety and clinical efficacy. As a foundational therapeutic option in routine dermatological practice, access to phototherapy contributes meaningfully to sustained disease control and overall patient outcomes. Nevertheless, comprehensive nationwide data describing real-world utilization, particularly within universal health coverage systems, remain limited. A clearer understanding of patterns of access may therefore offer valuable insight into the organization and delivery of dermatological care. Objectives: To quantify socioeconomic and regional inequality in UV phototherapy utilization and identify determinants of access within a universal health coverage system. Methods: This nationwide cross-sectional study (January-December 2023) integrated individual-level administrative health insurance data with a facility-based survey conducted across Thailand's 13 health regions to assess the availability of dermatologists and UV phototherapy devices. Patients with psoriasis ( Results: Among 49 219 identified patients with psoriasis (202 776 encounters), 16 188 were classified as having moderate-to--severe disease. Of these, only 3.3% received UV phototherapy. Utilization was concentrated in higher-income provinces, as reflected by a positive Concentration Index of 0.213. In multivariable analysis, access to phototherapy was independently associated with age, psoriasis subtype, insurance scheme, geographical region, provincial income level, and the availability of dermatologists and phototherapy devices. Conclusions: Access to phototherapy in Thailand remains limited and unequally distributed despite universal insurance coverage. Reducing disparities in workforce distribution and service capacity may enhance equitable access to this core dermatological treatment modality and support more equitable long-term disease control in routine clinical practice.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.